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Abstract 
Intravascular papillary endothelial hyperplasia (IPEH) is a benign  endothelial proliferation, usually intravascular, 
that may mimic  angiosarcoma. In this report, four new cases of IPEH involving the oral  region are described. 
The affected sites were the lower lip, labial  comissure and the submandibular region. After clinical evaluation, the 
complete removal of the lesions showed a circumscribed and soft mass.  Histologically, the major feature was a 
reactive proliferation of  endothelial cells composed of small papillary structures with hypocellular  and hyalinized 
cores arising in an organized thrombus. Immunohistochemical  staining for CD34 was strongly positive in endothe-
lial cells. Vimentin and  laminin immunolabelling were also consistent with a vascular origin. In  order to verify 
the proliferative potential of the lesions, the Ki-67  antibody was used, revealing low percentage of labeled cells 
(<20%). No  immunoreactivity for GLUT-1 was observed. Since the complete removal is  curative, no additional 
treatment was necessary, and no signs of  recurrence  had been observed until now. Due to the particular features of 
IPEH, it is  important for pathologists and clinicians to become familiar with this  lesion. Additionally, the specific 
histological arrangement, including the  absence of cellular pleomorphism, mitotic activity and necrosis,  represents 
a guide to help in the differential diagnosis. Moreover, the vascular  origin  and the proliferative index should be 
assessed by immunohistochemistry in  order to provide an accurate diagnosis.   
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Introduction
Intravascular papillary endothelial hyperplasia (IPEH) 
is a relatively uncommon benign and non-neoplastic 
vascular lesion (1-4). It was first described by Masson 
in 1923, as an endothelial proliferation with associated 
thrombosis and fibrin deposition, leading to obliteration 
of the vascular lumen (1-4). It is histologically 
characterized by the presence of endothelium-lined 
papillary structures composed by a single layer of plump 
cells around a fibrin core that sometimes forms irregular 
anastomosing clefts, simulating an angiosarcoma (5-8). 
However, the absence of cellular pleomorphism, mitotic 
activity and necrosis represent a differential feature of 
IPEH (5). The prognosis of this lesion is excellent, and 
recurrence is an unusual finding. It is cured by simple 
excision in primary forms, and by treating the underlying 
condition in the secondary ones (6,8). Its pathogenesis 
is usually associated with trauma, but recently it has 
been reported as an unusual form of organized thrombus 
(6-8).
In this article, four additional cases of oral IPEH are 
presented with immunohistochemical findings and a 
brief review of the literature. Additionally, clinical and 
histological aspects are also discussed.
Case reports
Clinical, histological and immunohistological findings. 
All four cases presented here were previously approved 
for this purpose, by the appropriate institutional review 
board (IRB). The clinical data of the cases are summa-
rized in Table 1. Clinically, the lesions were asymptom-
atic and the affected sites included lower lip (2 cases), 
submandibular region (one case) and labial comissure 
(one case). The average patient age was 45 years (rang-
ing from 28 to 72 years), and the treatment was the com-
plete excision of the lesion. The cases date from 2000, 
2004 and 2006, and no signs of recurrence have been 
Table 1. Clinical findings of the 4 new oral IPEH cases
Clinical findings
ID Age Gender Site/size Clinical diagnosis
Evolution 
time
1 48 years Male
Multilobulated, non-ulce-
rated purple-red mass in 
Lower lip (10x10mm)
Mucocele 11 months
2 28 years Female Nodule in Submandibular region (15x10mm) Not informed 5 months
3 32 years Male
Non-ulcerated, red-
dish soft mass in Lower 
lip(10x10mm)
Pleomorphic 
adenoma 4 months
4 72 years Male
Non-ulcerated, reddish 
soft mass in Labial comis-
sure (12x7mm)
Pyogenic 
granuloma 1 year
reported until now. Additionally, in a total of 60.000 oral 
biopsies experienced in our diagnosis service, only these 
four IPEH were found among 1650 vascular lesions. Mi-
croscopically, sections of all cases revealed a pseudo-
encapsulated mass confined within a dilated vascular 
space, represented by papillary fronds lined by prolif-
erating endothelium. Small collagenized structures sur-
rounded by granulation tissue were observed (Fig. 1A). 
These structures were lined by a single layer of plump 
endothelium and showed hypocellular and hyalinized 
cores (Fig. 1B). 
An associated thrombus was also seen, but no significant 
atypia, mitotic activity or necrosis were present. Immu-
nohistochemical reactions for CD-34 and vimentin re-
vealed strong positivity in the lining endothelial cells 
confirming the vascular origin of the lesion (Fig. 1C). 
Laminin and vimentin were also positively stained in the 
mesenchymal component (Fig. 1D,1E). Ki-67 antibody 
(Fig. 1F) labeled less than 20% of the cell component of 
the lesion and GLUT-1 was negative. These findings are 
in conformity with the diagnosis of the IPEH.
Discussion
Although vascular lesions are relatively common in the 
oral region, IPEH is an uncommon benign, non-neo-
plastic, vascular lesion (1-4), comprising approximate-
ly 2% of the benign and malignant vascular tumors of 
the skin and subcutaneous tissues (8). The differential 
diagnosis includes pyogenic granuloma, hemangioma 
and angiosarcoma (2,3,5,8-10). However, angiosarco-
mas usually occur in different clinical settings and are 
extravascular with an infiltrative growth pattern that 
dissects through collagen bundles. Additionally, these 
lesions display moderate-to-marked cytologic atypia 
with prominent mitotic activity (2). The IPEH can be 
distinguished from other lesions due to its frequently 
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Fig. 1. Histopathologic and immunohistochemical aspects. A, Small collagenized structures surrounded by a fibrous 
stroma (original magnification 25X). B, Papillae structures lined by a single layer of plump endothelium and showing 
hypocellular and hyalinized cores (original magnification 100X); C, Strong immunopositivity for CD-34 in most of 
the endothelial cells (original magnification 100X). D, Immunopositivity for laminin in the endothelial cells inside the 
lesion (original magnification 100X). E, Immunopositivity for vimentin in the lining endothelial cells (original magni-
fication 100X). F, Weak immunopositivity for Ki-67 in the endothelial cells.
well-circumscribed or encapsulated feature, with the 
proliferative process entirely limited by a vascular wall 
and characterized by papillary fronds. Moreover, IPEH 
is generally associated with a thrombus, which precedes 
the formation of the fronds and serves as a matrix for 
their development (10). The present cases were not com-
pletely encapsulated, but a thrombus was seen in all of 
them.
As observed in data provided here, the clinical hypothe-
sis included pyogenic granuloma, pleomorphic adenoma 
and mucocele, but they did not include IPEH. It points 
out the importance of a better knowledge of this lesion 
among clinicians in order to include it in their differen-
tial diagnosis. Generally, the complete surgical excision 
is the best therapy for patients with IPEH, being both di-
agnostic and curative. Recurrence is unusual, being only 
reported when the excision is not complete (6) or when 
an underlying vascular lesion, such as an intramuscular 
hemangioma or pyogenic granuloma is associated to the 
lesion (5,8).
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Clinically, IPEH presents as a tender firm mass and red-
dish-blue color to the overlying skin or mucous mem-
brane, as observed in the four reported cases. The pa-
tients ages range from 9 months to 80 years, which was 
observed in the cases report here. On the other hand, the 
higher incidence in females as compared to males (6,8) 
could not be seen in the 4 cases reported in this paper. 
According to the literature, approximately 80 cases of 
oral IPEH were described from 1976 to 2006, and they 
were slightly more frequent in the lower lip, followed by 
upper lip, tongue, buccal mucosa and mandibular vesti-
bule (1-4,7,10,11). In this report, it was found that two 
cases involved the lower lip, corroborating the literature 
data. The other two cases presented unusual affected 
sites (labial comissure and submandibular region), de-
serving particular attention.
Immunohistochemically, the vascular origin of the 
lesion was demonstrated by its positive reaction for 
CD34 and vimentin (2). In agreement to the literature 
(2,10), vimentin reacted not only with the mesenchymal 
cells but also with endothelial cells, suggesting that the 
present lesions are in an early stage of development. On 
the other hand, Ki-67 positive cells were rarely seen in 
all of the four cases, indicating that the proliferating 
activity was low. GLUT-1, a protein constitutively found 
in the placenta, erythrocytes, and fetal membranes, has 
been suggested as a useful auxiliary marker for the 
diagnosis of the oral benign vascular lesions (12). The 
present results showed negative reaction to GLUT-1, in 
agreement to a previous study presented by Johann et 
al. (12). 
Benign vascular tumors are very common and it is often 
difficult to determine whether they are malformations, 
true neoplasms or, in some cases, reactive processes. In 
the cases presented here, since the histological features 
suggested a vascular origin, the authors used the CD34 
to confirm this hypothesis. Although it is known that 
CD34 is a good vascular marker, it is also accepted 
that vascular lesions are very difficult to distinguish 
using only immunohistochemistry. In general, CD31 
and CD34 are the recommended markers for benign 
vascular lesions and, according to the histological 
features of each particular case, other markers can be 
used, such as muscle-specific actin (2). Particularly, 
the immunohistochemistry represents an important 
adjunctive procedure in the diagnosis of angiosarcomas 
(specially for poorly differentiated forms in which 
vascular channel formation is difficult to identify). As 
well as in benign vascular lesions, angiosarcomas express 
a greater or lesser degree of the usual vascular antigens, 
including von Willebrand factor, CD31 and CD34. Based 
on this, to assess if IPEH could be differentiated from 
malignant vascular tumors, the proper approach should 
be the analysis of histological aspects (e.g. mitosis, 
pleomorphism) (2,6).
In conclusion, the present report was focused on the 
description of clinical, histological and immunohisto-
chemical findings of the IPEH that might be helpful for 
clinicians. The authors also point to Ki-67 as a good 
marker of the proliferative potential of these lesions, in 
order to predict possible recurrences or misdiagnosis. 
Moreover, it is important for oral pathologists and 
clinicians to be familiarized with this lesion since it 
is rare and can be misdiagnosed as an angiosarcoma. 
Awareness of this lesion will prevent incorrect diagnosis 
and avoid aggressive treatment.
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